UNSPSC 51271609: Clodacaine

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H743H7R6YE. European Medicines Agency schedules Clodacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06688MIG. Clodacaine generally arises in the molecular formula C16H26CLN3O.

The term CLODACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, list 5.) CLODACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clodacaine under HS 29242995 and SITC 51479. As of Q4 2014, CLODACAINE remains the US FDA Preferred Term for this commodity. Clodacaine bears US NLM identifiers UMLS ID C2699358 and NCI Concept Code C77322. SMILES: CLC1C(NC(=O)CN(CCN(CC)CC)CC)CCCC1.

UNSPSC 51271609 Clodacaine, a Commodity code, describes a local anesthetic pharmaceutical product that state and local governments procure for use in medical facilities, emergency services, and health departments. The code covers clodacaine itself — a topical or injectable anesthetic agent — as a finished pharmaceutical product rather than raw chemical ingredients or compounding services. State and local health systems, correctional facilities, emergency medical services, and public health clinics use clodacaine for minor surgical procedures, wound treatment, dental work, and pain management in clinical settings.

The source contains no recent state or local contract opportunities tagged to this code. Without posted solicitations, issuing-body concentration, geographic spread, and representative procurement activity cannot be characterized from current market data.